ursodeoxycholic acid

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
392.57 4 3 4.48 JN_441 None Not checked

SMILES: C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

Supramolecules

Namelog KSDpHT(°C)MethodRef
[pyrene-appended GCD (g-P1)](1).[ursodeoxycholic acid] 4.63 25.0 absorption and fluorescence spectroscopy Akihiko Ueno 1990

ursodeoxycholic acid

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
392.57 4 3 4.48 SF_C1446 None Not checked

SMILES: C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

Supramolecules

Namelog KSDpHT(°C)MethodRef
[phenolphthalein-modified b-CD](1).[ursodeoxycholic acid ] 5.59 9.4 25.0 Absorption and induced circular dichroism spectroscopy Tetsuo Kuwabara 1998
[alizarin yellow-modified b-cyclodextrin](1).[ursodeoxycholic acid ] 4.97 9.4 25.0 Absorption and induced circular dichroism spectroscopy Tetsuo Kuwabara 1998

valdecoxib

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
314.36 4 1 4.75 SF_C598 None Not checked

SMILES: Cc1onc(c2ccccc2)c1c3ccc(cc3)[S](N)(=O)=O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[sulfobutylether-b-cyclodextrin](1).[valdecoxib] 3.15 6.8 25.0 UV-vis spectroscopy Tayade Pralhad 2005
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[valdecoxib] 2.48 6.8 25.0 UV-vis spectroscopy Tayade Pralhad 2005
[b-Cyclodextrin](1).[valdecoxib] 2.17 6.8 25.0 UV-vis spectroscopy Tayade Pralhad 2005

valeric acid

Supramolecules

Namelog KSDpHT(°C)MethodRef
[a-Cyclodextrin](1).[valeric acid] 2.50 1.32 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[b-Cyclodextrin](1).[valeric acid] 2.28 1.10 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[g-Cyclodextrin](1).[valeric acid] 1.13 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[valeric acid] 2.00 0.77 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Sulfated-b-Cyclodextrin](1).[valeric acid] 1.12 0.43 7.0 22.0 NMR titration Daniel W. Armstrong 2006
[Carboxymethylated-b-Cyclodextrin (DS ~3.5)](1).[valeric acid] 1.47 0.43 7.0 22.0 NMR titration Daniel W. Armstrong 2006

vanillin

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[vanillin] 4.05 3.26 7.0 20.0 NMR spectroscopy Soundar Divakar 1990

vinpocetine

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
350.45 3 0 4.09 SF_C832 None Not checked

SMILES: CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c5ccccc5n1c4[C@H]23

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[vinpocetine] 1.85 7.0 22.0 UV-vis spectroscopy Laura Ribeiro 2002
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[vinpocetine] 1.54 7.0 22.0 UV-vis spectroscopy Laura Ribeiro 2002

vinpocetine

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
350.45 3 0 4.09 SF_C936 None Not checked

SMILES: CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c5ccccc5n1c4[C@H]23

Supramolecules

Namelog KSDpHT(°C)MethodRef
[sulfobutylether-b-cyclodextrin](1).[vinpocetine] 2.53 7.0 21.0 UV-vis spectroscopy Francisco Veiga 2003
[sulfobutylether-b-cyclodextrin](1).[vinpocetine] 2.53 0.90 7.0 22.0 UV-vis spectroscopy Francisco J.B. Veiga 2003

vinpocetine

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
350.45 3 0 4.09 SF_C944 None Not checked

SMILES: CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c5ccccc5n1c4[C@H]23

Supramolecules

Namelog KSDpHT(°C)MethodRef

warfarin

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
308.33 3 1 3.61 SF_C1751 None Not checked

SMILES: CC(=O)CC(c1ccccc1)C2=C(O)Oc3ccccc3C2=O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[b-Cyclodextrin](1).[warfarin] 2.73 1.28 7.4 37.0 Fluorescence spectroscopy Serdar Ates 1994
[b-Cyclodextrin](1).[warfarin] 2.72 7.4 37.0 High-performance affinity chromatography David S. Hage 2004
[b-Cyclodextrin](1).[warfarin] 2.80 1.2 37.0 UV spectroscopy G. Zingone 2005
[b-Cyclodextrin](1).[warfarin] 2.49 5.0 37.0 UV spectroscopy G. Zingone 2005
[b-Cyclodextrin](1).[warfarin] 2.00 7.4 37.0 UV spectroscopy G. Zingone 2005
[b-Cyclodextrin](1).[warfarin] 2.47 5.5 37.0 UV spectroscopy G. Zingone 2005
[b-Cyclodextrin](1).[warfarin] 2.74 9.5 25.0 fluorescence spectroscopy Mamoru Kamiya 1997
[b-Cyclodextrin](1).[warfarin] 2.73 7.4 fluorescence spectroscopy Mamoru Kamiya 1997
[b-Cyclodextrin](1).[warfarin] 2.72 HPLC Mamoru Kamiya 1997
[b-Cyclodextrin](1).[warfarin] 2.17 infrared spectroscopy, differencial scanning calorimetry Mamoru Kamiya 1997
[2-O-(2-Hydroxy)propyl-b-Cyclodextrin](1).[warfarin] 2.65 1.26 7.4 37.0 Fluorescence spectroscopy Serdar Ates 1994
[Randomly methylated-b-Cyclodextrin (DS ~12)](1).[warfarin] 2.05 0.78 7.4 37.0 Fluorescence spectroscopy Serdar Ates 1994

warfarin

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
308.33 3 1 3.61 SF_C945 None Not checked

SMILES: CC(=O)CC(c1ccccc1)C2=C(O)Oc3ccccc3C2=O

Supramolecules

Namelog KSDpHT(°C)MethodRef

warfarin

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
308.33 3 1 3.61 JN_192 None Not checked

SMILES: CC(=O)CC(c1ccccc1)C2=C(O)Oc3ccccc3C2=O

Supramolecules

Namelog KSDpHT(°C)MethodRef
[a-Cyclodextrin](1).[warfarin] 1.58 9.5 25.0 fluorescence spectroscopy Mamoru Kamiya 1997
[Heptakis(2,6-di-O-Methyl)-b-Cyclodextrin (DS ~14) isomeric purity >50%](1).[warfarin] 2.45 9.5 25.0 fluorescence spectroscopy Mamoru Kamiya 1997
[g-Cyclodextrin](1).[warfarin] 2.28 9.5 25.0 fluorescence spectroscopy Mamoru Kamiya 1997

warfarin

MW HBA HBD LogP CAS Suppliers Supplier IDs Storage ID Quantity Class PAINS
308.33 3 1 3.61 JN_AL_1 None Not checked

SMILES: CC(=O)CC(c1ccccc1)C2=C(O)Oc3ccccc3C2=O

Supramolecules

Namelog KSDpHT(°C)MethodRef